INVO Fertility (IVF) Stock Rockets 145% on Surprise Q2 Earnings Beat
TLDR
- INVO Fertility (IVF) stock surged nearly 145% on Monday after releasing its Q2 2026 earnings report.
- The company posted diluted EPS of $0.35, beating the analyst estimate of -$0.70 by $1.05.
- Revenue came in at $2.17M-$2.18M, slightly missing the $2.4M consensus estimate.
- Growth was driven by a full-quarter contribution from Family Beginnings and the acquisition of a Birmingham, Alabama clinic.
- AI analyst Spark rates IVF stock Neutral with a $0.94 price target, citing ongoing cash burn.
INVO Fertility (IVF) stock exploded 145% on Monday after the company dropped its Q2 2026 earnings report, catching Wall Street off guard with a massive EPS beat.
The stock closed at $0.97 before the move. It had been down 74% year-to-date and 98% over the past 12 months, so Mondayโs jump came from a very low base.
The company reported diluted EPS of $0.35 for Q2 2026. That beat the analyst estimate of -$0.70 by $1.05. A year ago, the adjusted EPS was -$364.23.
๐จ $IVF (INVO Fertility) Q2 2026 Results
Revenue up 17%โฆ
clinic growth + acquisition drive, net income turns positive on one-time gain ๐๐ถโฆ Continue reading the full article at the original source below.
This content is automatically aggregated. Full credit goes to the original publisher (coincentral.com).
